Cargando…
Janus effect of glucocorticoids on differentiation of muscle fibro/adipogenic progenitors
Muscle resident fibro-adipogenic progenitors (FAPs), support muscle regeneration by releasing cytokines that stimulate the differentiation of myogenic stem cells. However, in non-physiological contexts (myopathies, atrophy, aging) FAPs cause fibrotic and fat infiltrations that impair muscle function...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093513/ https://www.ncbi.nlm.nih.gov/pubmed/32210313 http://dx.doi.org/10.1038/s41598-020-62194-6 |
_version_ | 1783510298943029248 |
---|---|
author | Cerquone Perpetuini, Andrea Giuliani, Giulio Reggio, Alessio Cerretani, Mauro Santoriello, Marisabella Stefanelli, Roberta Palma, Alessandro Vumbaca, Simone Harper, Steven Castagnoli, Luisa Bresciani, Alberto Cesareni, Gianni |
author_facet | Cerquone Perpetuini, Andrea Giuliani, Giulio Reggio, Alessio Cerretani, Mauro Santoriello, Marisabella Stefanelli, Roberta Palma, Alessandro Vumbaca, Simone Harper, Steven Castagnoli, Luisa Bresciani, Alberto Cesareni, Gianni |
author_sort | Cerquone Perpetuini, Andrea |
collection | PubMed |
description | Muscle resident fibro-adipogenic progenitors (FAPs), support muscle regeneration by releasing cytokines that stimulate the differentiation of myogenic stem cells. However, in non-physiological contexts (myopathies, atrophy, aging) FAPs cause fibrotic and fat infiltrations that impair muscle function. We set out to perform a fluorescence microscopy-based screening to identify compounds that perturb the differentiation trajectories of these multipotent stem cells. From a primary screen of 1,120 FDA/EMA approved drugs, we identified 34 compounds as potential inhibitors of adipogenic differentiation of FAPs isolated from the murine model (mdx) of Duchenne muscular dystrophy (DMD). The hit list from this screen was surprisingly enriched with compounds from the glucocorticoid (GCs) chemical class, drugs that are known to promote adipogenesis in vitro and in vivo. To shed light on these data, three GCs identified in our screening efforts were characterized by different approaches. We found that like dexamethasone, budesonide inhibits adipogenesis induced by insulin in sub-confluent FAPs. However, both drugs have a pro-adipogenic impact when the adipogenic mix contains factors that increase the concentration of cAMP. Gene expression analysis demonstrated that treatment with glucocorticoids induces the transcription of Gilz/Tsc22d3, an inhibitor of the adipogenic master regulator PPARγ, only in anti-adipogenic conditions. Additionally, alongside their anti-adipogenic effect, GCs are shown to promote terminal differentiation of satellite cells. Both the anti-adipogenic and pro-myogenic effects are mediated by the glucocorticoid receptor and are not observed in the presence of receptor inhibitors. Steroid administration currently represents the standard treatment for DMD patients, the rationale being based on their anti-inflammatory effects. The findings presented here offer new insights on additional glucocorticoid effects on muscle stem cells that may affect muscle homeostasis and physiology. |
format | Online Article Text |
id | pubmed-7093513 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-70935132020-03-27 Janus effect of glucocorticoids on differentiation of muscle fibro/adipogenic progenitors Cerquone Perpetuini, Andrea Giuliani, Giulio Reggio, Alessio Cerretani, Mauro Santoriello, Marisabella Stefanelli, Roberta Palma, Alessandro Vumbaca, Simone Harper, Steven Castagnoli, Luisa Bresciani, Alberto Cesareni, Gianni Sci Rep Article Muscle resident fibro-adipogenic progenitors (FAPs), support muscle regeneration by releasing cytokines that stimulate the differentiation of myogenic stem cells. However, in non-physiological contexts (myopathies, atrophy, aging) FAPs cause fibrotic and fat infiltrations that impair muscle function. We set out to perform a fluorescence microscopy-based screening to identify compounds that perturb the differentiation trajectories of these multipotent stem cells. From a primary screen of 1,120 FDA/EMA approved drugs, we identified 34 compounds as potential inhibitors of adipogenic differentiation of FAPs isolated from the murine model (mdx) of Duchenne muscular dystrophy (DMD). The hit list from this screen was surprisingly enriched with compounds from the glucocorticoid (GCs) chemical class, drugs that are known to promote adipogenesis in vitro and in vivo. To shed light on these data, three GCs identified in our screening efforts were characterized by different approaches. We found that like dexamethasone, budesonide inhibits adipogenesis induced by insulin in sub-confluent FAPs. However, both drugs have a pro-adipogenic impact when the adipogenic mix contains factors that increase the concentration of cAMP. Gene expression analysis demonstrated that treatment with glucocorticoids induces the transcription of Gilz/Tsc22d3, an inhibitor of the adipogenic master regulator PPARγ, only in anti-adipogenic conditions. Additionally, alongside their anti-adipogenic effect, GCs are shown to promote terminal differentiation of satellite cells. Both the anti-adipogenic and pro-myogenic effects are mediated by the glucocorticoid receptor and are not observed in the presence of receptor inhibitors. Steroid administration currently represents the standard treatment for DMD patients, the rationale being based on their anti-inflammatory effects. The findings presented here offer new insights on additional glucocorticoid effects on muscle stem cells that may affect muscle homeostasis and physiology. Nature Publishing Group UK 2020-03-24 /pmc/articles/PMC7093513/ /pubmed/32210313 http://dx.doi.org/10.1038/s41598-020-62194-6 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Cerquone Perpetuini, Andrea Giuliani, Giulio Reggio, Alessio Cerretani, Mauro Santoriello, Marisabella Stefanelli, Roberta Palma, Alessandro Vumbaca, Simone Harper, Steven Castagnoli, Luisa Bresciani, Alberto Cesareni, Gianni Janus effect of glucocorticoids on differentiation of muscle fibro/adipogenic progenitors |
title | Janus effect of glucocorticoids on differentiation of muscle fibro/adipogenic progenitors |
title_full | Janus effect of glucocorticoids on differentiation of muscle fibro/adipogenic progenitors |
title_fullStr | Janus effect of glucocorticoids on differentiation of muscle fibro/adipogenic progenitors |
title_full_unstemmed | Janus effect of glucocorticoids on differentiation of muscle fibro/adipogenic progenitors |
title_short | Janus effect of glucocorticoids on differentiation of muscle fibro/adipogenic progenitors |
title_sort | janus effect of glucocorticoids on differentiation of muscle fibro/adipogenic progenitors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093513/ https://www.ncbi.nlm.nih.gov/pubmed/32210313 http://dx.doi.org/10.1038/s41598-020-62194-6 |
work_keys_str_mv | AT cerquoneperpetuiniandrea januseffectofglucocorticoidsondifferentiationofmusclefibroadipogenicprogenitors AT giulianigiulio januseffectofglucocorticoidsondifferentiationofmusclefibroadipogenicprogenitors AT reggioalessio januseffectofglucocorticoidsondifferentiationofmusclefibroadipogenicprogenitors AT cerretanimauro januseffectofglucocorticoidsondifferentiationofmusclefibroadipogenicprogenitors AT santoriellomarisabella januseffectofglucocorticoidsondifferentiationofmusclefibroadipogenicprogenitors AT stefanelliroberta januseffectofglucocorticoidsondifferentiationofmusclefibroadipogenicprogenitors AT palmaalessandro januseffectofglucocorticoidsondifferentiationofmusclefibroadipogenicprogenitors AT vumbacasimone januseffectofglucocorticoidsondifferentiationofmusclefibroadipogenicprogenitors AT harpersteven januseffectofglucocorticoidsondifferentiationofmusclefibroadipogenicprogenitors AT castagnoliluisa januseffectofglucocorticoidsondifferentiationofmusclefibroadipogenicprogenitors AT brescianialberto januseffectofglucocorticoidsondifferentiationofmusclefibroadipogenicprogenitors AT cesarenigianni januseffectofglucocorticoidsondifferentiationofmusclefibroadipogenicprogenitors |